Assembly Biosciences, Inc. (ASMB) vs Ovid Therapeutics (OVID)
Assembly Biosciences, Inc. and Ovid Therapeutics are both Biotechnology companies. Assembly Biosciences, Inc. and Ovid Therapeutics are of similar size ($487.3M and $481.7M). Ovid Therapeutics has negative trailing earnings, so its P/E is not meaningful; Assembly Biosciences, Inc. trades at 23.2×. Ovid Therapeutics grew revenue faster over the last twelve months: 1,333.4% against 125.1%. Assembly Biosciences, Inc. has the higher net margin (−0.06% vs −439.1%) and the higher return on invested capital (0.00% vs −35.1%). Across the 17 metrics below, Assembly Biosciences, Inc. leads on 15 and Ovid Therapeutics on 2.
Valuation
Profitability
| Metric | ASMB | OVID | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (11.75%) | (742.97%) | 0.00% |
| Net margin | (0.06%) | (439.11%) | 0.00% |
| Free cash flow margin | (51.53%) | (697.30%) | 0.00% |
| Return on equity | (0.03%) | (25.97%) | (57.72%) |
| Return on assets | (0.02%) | (22.30%) | (49.22%) |
| Return on invested capital | 0.00% | (35.11%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack